TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34360095

Group type: EXPERIMENTAL
Intervention: SEE-C (Simulation-based Empathy Enhancement program for Caregivers)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (caregivers who did not experience SEE-C)
Number of subjects: 100
Study: 35710102

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 12 intervals (1.5 min) at 85–90% HRmax, separated by 2 min at 55–60% HRmax, 3 sessions per week for 12 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT) - 42 min of cycling at 70% HRmax
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group - no specific intervention mentioned
Number of subjects: 66
Study: 33360089

Group type: EXPERIMENTAL
Intervention: Broadband noise at 55 dBA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Broadband noise at 75 dBA
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ambient noise at 40 dBA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All noise groups (55 dBA and 75 dBA)
Number of subjects: 45
Study: 32869588

Group type: EXPERIMENTAL
Intervention: Ginger-separated moxibustion
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal diet and proper physical exercise (Control)
Number of subjects: 62
Study: 35863110

Group type: EXPERIMENTAL
Intervention: MSI-high gastric cancer in males
Number of subjects: 1307

Group type: EXPERIMENTAL
Intervention: MSI-high gastric cancer in females
Number of subjects: 1307

Group type: COMPARATOR
Intervention: MSS/MMRP gastric cancer in males
Number of subjects: 1307

Group type: COMPARATOR
Intervention: MSS/MMRP gastric cancer in females
Number of subjects: 1307
Study: 34357673

Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer everolimus‐eluting stents (BP-EES)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Durable polymer everolimus‐eluting stents (DP-EES)
Number of subjects: 104
Study: 35277414

Group type: EXPERIMENTAL
Intervention: Selective Decontamination of the Digestive tract (SDD)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Standard infection control measures
Number of subjects: 324
Study: 36432444

Group type: EXPERIMENTAL
Intervention: Bovine Colostrum (BC)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Conventional Fortifier (CF)
Number of subjects: 242
Study: 32070291

Group type: EXPERIMENTAL
Intervention: iCaPPS©
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 151
Study: 33127493

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Tape measure (TM)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS) with no RNI
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS) with extensive RNI
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS) with ALND
Number of subjects: 498
Study: 32142536

Group type: EXPERIMENTAL
Intervention: CanRisk prototype tool
Number of subjects: 75
Study: 36443491

Group type: EXPERIMENTAL
Intervention: α-lactalbumin (40 g)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Handgrip contraction (40% of maximal force)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Zein (isonitrogenous beverage)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Corn-starch (isocaloric beverage)
Number of subjects: 13
Study: 33559440

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with conventional visual stimulation therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional visual stimulation therapy
Number of subjects: 60
Study: 32961528

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 36503860

Group type: EXPERIMENTAL
Intervention: HA-coated TADs
Number of subjects: 92

Group type: COMPARATOR
Intervention: Uncoated TADs
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: TADs placed on the left side
Number of subjects: 92
Study: 33368836

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic intervention
Number of subjects: 386

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 386
Study: 32046910

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 1116
Study: 36102482

Group type: EXPERIMENTAL
Intervention: Mesh tacked
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Mesh fixed with fibrin glue
Number of subjects: 63

Group type: COMPARATOR
Intervention: No mesh fixation
Number of subjects: 63
Study: 35393316

Group type: EXPERIMENTAL
Intervention: Supervised acute physical exercise therapy prior to immune-chemotherapy infusion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unsupervised home-based walking programme with an activity tracker
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Physical Activity recommendations and two nutritional assessments
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study: 36088501

Group type: EXPERIMENTAL
Intervention: Personalized feedback profile
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 176
Study: 33654272

Group type: EXPERIMENTAL
Intervention: LPG stove and cylinder refills as needed
Number of subjects: 1414

Group type: EXPERIMENTAL
Intervention: Fan-assisted efficient biomass-burning cookstove
Number of subjects: 1414

Group type: COMPARATOR
Intervention: Control arm (three-stone fires)
Number of subjects: 1414
Study: 32451458

Group type: EXPERIMENTAL
Intervention: Causal Analysis Using Summary Effect estimates (CAUSE)
Number of subjects: 0
Study: 35294018

Group type: EXPERIMENTAL
Intervention: Iced-sheet cooling (ISC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no ISC)
Number of subjects: 0
Study: 36113009

Group type: EXPERIMENTAL
Intervention: Robotic pet
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 220
Study: 33712080

Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia (OFA) using dexmedetomidine and lidocaine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard general anesthesia using remifentanil
Number of subjects: 78
Study: 32827458

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention for intensive BP treatment including protocol‐based treatment using the SPRINT intensive BP management algorithm, dissemination of SPRINT findings, BP audit and feedback, home BP monitoring, and health coaching.
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention for intensive BP treatment
Number of subjects: 1260
Study: 36228984

Group type: EXPERIMENTAL
Intervention: ZSQI plus a stepped care intervention for suicide prevention (SC-SP)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Zero Suicide Quality Improvement (ZSQI)
Number of subjects: 300
Study: 33331495

Group type: EXPERIMENTAL
Intervention: ACT‐BBI‐I
Number of subjects: 45

Group type: COMPARATOR
Intervention: CBT‐I
Number of subjects: 45
Study: 35368119

Group type: EXPERIMENTAL
Intervention: Linear mixed effects models (LMMs) for handling missing data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple imputation methods
Number of subjects: 0
Study: 33245245

Group type: EXPERIMENTAL
Intervention: Sleep education and PHM intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sleep education only
Number of subjects: 24
Study: 32299120

Group type: EXPERIMENTAL
Intervention: Real AMPS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo AMPS
Number of subjects: 25
Study: 35238969

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose (ULD) CT
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard-dose (SD) CT
Number of subjects: 63
Study: 33574163

Group type: EXPERIMENTAL
Intervention: Immediate antibiotic prescription (IAP)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Delayed antibiotic prescription (DAP)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: No antibiotic prescription (NAP)
Number of subjects: 436
Study: 34872441

Group type: EXPERIMENTAL
Intervention: SOCS‐2 gene expression at diagnosis in blast crisis patients
Number of subjects: 123

Group type: COMPARATOR
Intervention: SOCS‐2 gene expression at diagnosis
Number of subjects: 123
Study: 33301246

Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine (30 μg per dose, two doses, 21 days apart)
Number of subjects: 43448

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43448

Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine
Number of subjects: 43448
Study: 35279718

Group type: EXPERIMENTAL
Intervention: EV 2 mg + DNG 2-3 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EE 0.03 mg + DNG 2 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: DNG 2 mg
Number of subjects: 59
Study: 34338369

Group type: EXPERIMENTAL
Intervention: Telehealth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 34910089

Group type: EXPERIMENTAL
Intervention: High-protein low-glycemic index diet (HPLGI: 25%-28% of energy from protein, glycemic index ≤ 55)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Moderate-protein moderate-glycemic index diet (MPMGI: 15%-18% of energy from protein, glycemic index ∼60)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: High-protein low-glycemic index diet (HPLGI)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Moderate-protein moderate-glycemic index diet (MPMGI)
Number of subjects: 279
Study: 32852904

Group type: EXPERIMENTAL
Intervention: Mepivacaine (52.5 mg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Hyperbaric Bupivacaine (11.25 mg)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Isobaric Bupivacaine (12.5 mg)
Number of subjects: 154
Study: 36151010

Group type: EXPERIMENTAL
Intervention: 40 Hz stimulation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 4000 Hz stimulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: 10,000 Hz stimulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 14
Study: 33980995

Group type: EXPERIMENTAL
Intervention: Multivitamin and vitamin D 4000 IU/d
Number of subjects: 62

Group type: COMPARATOR
Intervention: Vitamin D 1200 IU/d (Control)
Number of subjects: 62
Study: 32378654

Group type: EXPERIMENTAL
Intervention: IGB plus low-carbohydrate diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: IGB plus calorie-restricted diet
Number of subjects: 31
Study: 35905197

Group type: EXPERIMENTAL
Intervention: NXT15906F6 (2.5 gram/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 34243719

Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum block combined with fascia iliaca compartment block (group QF)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Transmuscular quadratus lumborum block (group Q)
Number of subjects: 54
Study: 33464318

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus best supportive care
Number of subjects: 413

Group type: COMPARATOR
Intervention: Placebo plus best supportive care
Number of subjects: 413
Study: 35064175

Group type: EXPERIMENTAL
Intervention: Cardiovascular exercise (CE) intervention for 2 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-CE control group
Number of subjects: 0
Study: 34729326

Group type: EXPERIMENTAL
Intervention: Oblique Axis (OAX)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Long Axis (LAX)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Short Axis (SAX)
Number of subjects: 210
Study: 36194352

Group type: EXPERIMENTAL
Intervention: Perindopril-based regimen
Number of subjects: 29463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29463
Study: 33779480

Group type: EXPERIMENTAL
Intervention: Ecological Momentary Intervention (EMI)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 55
Study: 32923417

Group type: EXPERIMENTAL
Intervention: Basic-Workshop (one-time 90-min workshop in rope skipping)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Champion-Program (10 lessons in rope skipping)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Control group (78 students)
Number of subjects: 486
Study: 35568489

Group type: EXPERIMENTAL
Intervention: Youth Culturally Adapted Manual Assisted Problem Solving Training (YCMAP) - 8-10 individual sessions over 3 months
Number of subjects: 652

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 652
Study: 32330971

Group type: EXPERIMENTAL
Intervention: Flexion group (affected leg elevated by 30 degrees at the hip and knee flexed by 30 degrees postoperatively)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extension group (affected knee fully extended postoperatively)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study: 32623375

Group type: COMPARATOR
Intervention: Arousal index in overweight/obese prepubertal children
Number of subjects: 151

Group type: COMPARATOR
Intervention: Minimum O2 saturation in overweight/obese prepubertal children
Number of subjects: 151

Group type: COMPARATOR
Intervention: Apnea-hypopnea index in overweight/obese pubertal children
Number of subjects: 151

Group type: COMPARATOR
Intervention: pCO2 in overweight/obese pubertal children
Number of subjects: 151
Study: 35725632

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) plus sterile water
Number of subjects: 126

Group type: COMPARATOR
Intervention: 24% oral sucrose
Number of subjects: 126
Study: 32631820

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ)
Number of subjects: 45
Study: 35791269

Group type: EXPERIMENTAL
Intervention: Epinephrine group from the PARAMEDIC2 trial
Number of subjects: 26019

Group type: COMPARATOR
Intervention: Baseline variables in a German EMS and health care system
Number of subjects: 26019

Group type: COMPARATOR
Intervention: Baseline plus treatment model in a German EMS and health care system
Number of subjects: 26019
Study: 33858875

Group type: EXPERIMENTAL
Intervention: eHealth programme comprising balance exercise, cognitive‐motor exercise and cognitive‐behavioural therapy
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: eHealth programme
Number of subjects: 518

Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 518
Study: 32163721

Group type: EXPERIMENTAL
Intervention: Partner's scent
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control scent
Number of subjects: 155
Study: 36150846

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS) technology
Number of subjects: 68

Group type: COMPARATOR
Intervention: Traditional learning methods (Control)
Number of subjects: 68
Study: 35134697

Group type: EXPERIMENTAL
Intervention: Pomegranate supplement for 4 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 33950030

Group type: EXPERIMENTAL
Intervention: Daily oral conjugated equine estrogen (CEE) (0.625 mg) plus medroxyprogesterone acetate (2.5 mg) for women with a uterus (5.7 years)
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: Daily oral CEE (0.625 mg) alone for women with a hysterectomy (7.2 years)
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: CVD risk scores (AHA/ACC and Framingham Heart Study)
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: Age and years since menopause
Number of subjects: 27347
Study: 32811740

Group type: EXPERIMENTAL
Intervention: Group Care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (traditional one-to-one care)
Number of subjects: 0
Study: 33836826

Group type: EXPERIMENTAL
Intervention: Ivermectin (300 mcg/kg) administered daily for three consecutive days
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo administered daily for three consecutive days
Number of subjects: 186
Study: 33635540

Group type: EXPERIMENTAL
Intervention: SUP (pantoprazole)
Number of subjects: 3291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3291
Study: 32176305

Group type: EXPERIMENTAL
Intervention: Transgender woman identification
Number of subjects: 297

Group type: COMPARATOR
Intervention: Smoking cigarettes monthly or less
Number of subjects: 297

Group type: COMPARATOR
Intervention: Smoking cigarettes daily
Number of subjects: 297

Group type: COMPARATOR
Intervention: Identifying as a sexual orientation other than heterosexual, gay, lesbian, or bisexual
Number of subjects: 297
Study: 35416163

Group type: EXPERIMENTAL
Intervention: Group B (anterior‐superior RCT type 1,2,3 or combination)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Group A (posterior‐superior RCT type 3, 4, 5 or combination)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (different shoulder surgery)
Number of subjects: 136
Study: 33249482

Group type: EXPERIMENTAL
Intervention: Sleep restriction (SR) condition: participants slept from 0300-0700 hours for three nights followed by a recovery night of 8-h sleep, repeated four times.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control: Eight-hour sleep per night.
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sleep restriction (SR) condition
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Control and Sleep restriction (SR) condition
Number of subjects: 45
Study: 35791906

Group type: EXPERIMENTAL
Intervention: Alcohol use days
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Cannabis use days
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Daily co-use of alcohol and cannabis
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sibling co-use days
Number of subjects: 99
Study: 34668237

Group type: EXPERIMENTAL
Intervention: Hair lotion containing creatine, acetyl tetrapeptide‐2 and B vitamins with mild shampoo
Number of subjects: 100

Group type: COMPARATOR
Intervention: Mild shampoo alone (control)
Number of subjects: 100
Study: 35584801

Group type: EXPERIMENTAL
Intervention: Highest quartile of waist circumference (WC) variability
Number of subjects: 10001

Group type: EXPERIMENTAL
Intervention: Highest quartile of body mass index (BMI) variability
Number of subjects: 10001

Group type: EXPERIMENTAL
Intervention: Highest quartile of BMI variability
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Lowest quartile of BMI variability
Number of subjects: 10001
Study: 34583667

Group type: EXPERIMENTAL
Intervention: Machine learning group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scale group
Number of subjects: 0
Study: 32672584

Group type: EXPERIMENTAL
Intervention: 2 trabecular micro-bypass stents (iStent trabecular micro-bypass; Glaukos Corporation)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Topical travoprost (once-daily)
Number of subjects: 101
Study: 33843490

Group type: EXPERIMENTAL
Intervention: Move in office with education (MOWE)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 46
Study: 33441359

Group type: EXPERIMENTAL
Intervention: CBT-based cigarette smoking cessation smartphone app intervention
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Text messaging-based control intervention
Number of subjects: 1200
Study: 33342719

Group type: EXPERIMENTAL
Intervention: Interactive and tailored short message reminders
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group (no SMS reminders)
Number of subjects: 209
Study: 35410489

Group type: EXPERIMENTAL
Intervention: Integrative score based on hemoglobin (HB), C-reactive protein to albumin ratio (CAR), and platelet to lymphocyte ratio (PLR)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: COHCP-based nomogram
Number of subjects: 421
Study: 33797667

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Hopelessness
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Self-concept
Number of subjects: 635
Study: 35256599

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 51
Study: 33048319

Group type: EXPERIMENTAL
Intervention: My eReport France® App (experimental arm)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Traditional reporting (control arm)
Number of subjects: 159
Study: 35786739

Group type: EXPERIMENTAL
Intervention: Classical Whipple
Number of subjects: 84

Group type: COMPARATOR
Intervention: PPPD (control group)
Number of subjects: 84
Study: 34879480

Group type: EXPERIMENTAL
Intervention: Nurse‐delivered care transition intervention
Number of subjects: 512

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 512
Study: 35019976

Group type: EXPERIMENTAL
Intervention: Accelerometry-measured moderate-to-vigorous physical activity (MVPA)
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: MVPA accumulated in ≥10-min bouts
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: Self-reported physical activity
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: Accelerometry-measured MVPA at 1 year
Number of subjects: 1978
Study: 33270930

Group type: EXPERIMENTAL
Intervention: Guideline-based multicomponent intervention to prevent physical restraints
Number of subjects: 0
Study: 32883333

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 0.5 mg/kg twice a day for 7 days, then 0.5 mg/kg once a day for 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (same volume as HC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35197358

Group type: EXPERIMENTAL
Intervention: Alitretinoin (AL)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Psoralen combined with ultraviolet A (PUVA)
Number of subjects: 500
Study: 34790015

Group type: EXPERIMENTAL
Intervention: peginterferon
Number of subjects: 139

Group type: COMPARATOR
Intervention: nucleos(t)ide analog (NUC)-based therapy
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Serum qHBcrAg
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Log HBcrAg at week 24
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Log HBcrAg at week 48
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Serum HBcrAg levels
Number of subjects: 139
Study: 32512314

Group type: EXPERIMENTAL
Intervention: Caseload midwifery
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1019
Study: 36004722

Group type: EXPERIMENTAL
Intervention: Breathing exercises (diaphragmatic and pursed lip breathing) performed for 10-15 minutes every morning/evening for eight weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 0
Study: 36029512

Group type: EXPERIMENTAL
Intervention: Formocresol
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 66